Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:698-704
Published online before print February 14, 2008, doi: 10.1161/ATVBAHA.107.160903
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/4/698    most recent
ATVBAHA.107.160903v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, J.
Right arrow Articles by Fay, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, J.
Right arrow Articles by Fay, W. P.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:698.)
© 2008 American Heart Association, Inc.


Cell Biology/Signaling

C-Reactive Protein Enhances Tissue Factor Expression by Vascular Smooth Muscle Cells

Mechanisms and In Vivo Significance

Jianbo Wu; Meredith J. Stevenson; Jordan M. Brown; Elizabeth A. Grunz; Tammy L. Strawn; William P. Fay

From the Department of Internal Medicine, University of Missouri School of Medicine, and Research Service, Harry S. Truman Memorial Veterans Affairs Hospital, Columbia, MO.

Correspondence to Jianbo Wu, MD, PhD, University of Missouri, MC314 McHaney Hall, One Hospital Drive DC095.00, Columbia, Missouri 65212. E-mail wuji{at}health.missouri.edu

Objective— We examined the impact of C-reactive protein (CRP) on vascular smooth muscle cell (VSMC) expression of tissue factor (TF) and TF pathway inhibitor (TFPI).

Methods and Results— TF mRNA, protein, and activity levels were significantly higher in VSMCs isolated from CRP-transgenic (Tg) mice than from wild-type (WT) mice. TFPI expression was significantly downregulated in CRP-Tg versus WT VSMCs. Transfection of human VSMCs with CRP expression plasmid significantly increased TF expression and decreased TFPI expression. Gene silencing of Fc{gamma} receptor IIIa (Fc{gamma}RIIIa) blocked the effect of CRP on VSMC TF expression. CRP activated p44/42, but not p38 or JNK MAP kinase (MAPK), and the effect of CRP on TF expression was blocked by pharmacological inhibitor of p44/42, but not p38 or JNK MAPK. Reactive oxygen species (ROS) scavengers blocked CRP-induced upregulation of VSMC TF expression. In vivo analyses revealed significant increases in TF expression and decreases in TFPI expression in carotid arteries of CRP-Tg mice versus WT mice.

Conclusion— CRP increases TF and decreases TFPI expression by VSMCs in vitro and in vivo. Induction of TF expression by CRP is mediated by Fc{gamma}RIIIa, p44/42 MAPK, and ROS generation. These data offer important insights into the role of CRP in the pathogenesis of arterial thrombosis.

We show that upregulation of C-reactive protein (CRP) expression increases tissue factor (TF) expression while decreasing TF pathway inhibitor expression in vascular smooth muscle cells, both in vitro and in vivo. Induction of TF expression by CRP is mediated by Fc{gamma} receptor IIIa, p44/42 MAP kinase, and reactive oxygen species generation.


Key Words: C-reactive protein • tissue factor • VSMC • thrombosis


Related Article:

Does Tissue Factor Expression by Vascular Smooth Muscle Cells Provide a Link Between C-Reactive Protein and Cardiovascular Disease?
Nigel Mackman and Mark B. Taubman
Arterioscler. Thromb. Vasc. Biol. 2008 28: 601-603. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Eur Respir JHome page
L. Lavie and P. Lavie
Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link
Eur. Respir. J., June 1, 2009; 33(6): 1467 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. Montecucco, F. Burger, G. Pelli, N. K. Poku, C. Berlier, S. Steffens, and F. Mach
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes
Rheumatology, March 1, 2009; 48(3): 233 - 242.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Devaraj, J.-M. Yun, C. Duncan-Staley, and I. Jialal
C-reactive protein induces M-CSF release and macrophage proliferation
J. Leukoc. Biol., February 1, 2009; 85(2): 262 - 267.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Devaraj, U. Singh, and I. Jialal
The Evolving Role of C-Reactive Protein in Atherothrombosis
Clin. Chem., February 1, 2009; 55(2): 229 - 238.
[Abstract] [Full Text] [PDF]